Patients with IBD have a higher risk for interstitial lung disease than the general population, with the risk being more ...

In 2021, ATYR completed a phase 1b/2a trial in pulmonary sarcoidosis, and have since started a phase 3 trial. Currently the ...

Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...

The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but ...

Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

With significant hedge fund interest and a share price under $10, Gossamer Bio, Inc. (NASDAQ:GOSS) secures a spot on our list ...

Advances in classification and treatment of idiopathic inflammatory myopathies highlight the role of biomarkers, ...

Legionnaires’ disease is a rare condition, and incidence is hard to estimate because diagnosis requires a suspicion of ...

Located in North Carolina, Liquidia Corporation (NASDAQ:LQDA) develops and commercializes treatments for rare cardiopulmonary ...

Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Pune: Infantry soldier Tariq Aziz (30) is set to return to active duty after undergoing a bilateral lung transplant — the ...

Beginning treatment for your lung cancer often brings questions surrounding what side effects will be experienced, according ...